Depression: Major Depression & Unipolar Varieties
Resources
Basic Information
Local ContentIntroduction and Types of DepressionRelated Disorders / ConditionsHistorical and Current UnderstandingsBiology, Psychology and SociologyTreatment - Medication and PsychotherapyAlternative Medicine and Self-Help ResourcesSpecial IssuesReferencesMore InformationTestsLatest News
Depression in Mid-Life Linked to Higher Odds for Later DementiaUse of Ecstasy, Speed by Teens Tied to Later DepressionDepressed Moms May Hinder Babies' SleepChronic Depression Patients Pick Acupuncture Over CounselingNewer Antidepressants May Be Safe for Parkinson's PatientsFDA Adds More Warnings to Antidepressant's LabelTalking About Weight Tied to Poor Self-Image, Depression: StudyLiving Alone Linked to Greater Risk of Depression: StudyAntidepressants May Raise Risk for Pregnancy ComplicationStudy Explains How Shock Therapy Might Ease Severe DepressionFirst Generic Lexapro ApprovedMothers on Antidepressants Less Likely to Breast-Feed: StudyMoms' Antidepressants May Affect Babies' Head Size: StudyDepression Could Worsen Mental Decline in Heart PatientsDad's Depression May Rub Off on Child's BehaviorMigraines May Raise a Woman's Odds of DepressionDepressed Kids May Be Targets for Bullying, Study SuggestsFluoxetine, Venlafaxine Tied to Drop in Adult Suicide BehaviorsNew Assay IDs Individuals With Major Depressive DisorderCould a Blood Test Help Spot Depression?Winter Doldrums Got You Down? Here's How to Bounce BackAntidepressants While Pregnant Linked to Slight Risk of Lung Problem in BabiesDeep Brain Stimulation Found Effective for Severe DepressionWith Depression, Helping Others May in Turn Help YouRacial Disparities Seem to Persist in Depression DiagnosisHoliday Blues May Signal DepressionBest Antidepressant May Depend on Patient: StudyMom-to-Be's Mental State May Affect Child's DevelopmentWhen Dads Have Depression, Kids May Be at Risk, TooAntidepressant Use Skyrocketed in Past 20 Years: CDCCaffeinated Coffee Reduces Women's Depression RiskFear of Antidepressants Keep Many From Disclosing DepressionAntidepressant Tied to Dangerous Heart Rhythm: FDAAbuse, Neglect in Childhood Linked to Depression in AdulthoodMoms' Depression Affects Kids' Brain Structure, Scans ShowDepressed Women Could Face Raised Risk of StrokeAmericans' Use of Antidepressants On the Rise: StudySpecific Criteria Beat DSM-IV in ID of Bipolar in Major DepressionPopular Antidepressants Not Always Best Choice for SeniorsChildhood Depression, Anxiety Tied to Pain in AdulthoodMajor Depression Strongly Linked to Social ConditionsDepression Higher in Wealthier NationsKids of Moms With History of Depression Seem Less HappyPrior Depression Can Leave People Sensitive to Life's WoesFirst Trimester Antidepressant Use Tied to Childhood ASDCity Living Tied to More Anxiety, Mood DisordersRecurrent Maternal Depression May Affect Child's BehaviorDepressed People Find It Hard to Stop Reliving Bad TimesCognitive Therapy Helps Depressed Drug AbusersREMIT Useful for Evaluating Depression Remission
Questions and AnswersVideosLinksBook ReviewsSelf-Help Groups
Related Topics

Anxiety Disorders
Bipolar Disorder
Suicide
Addictions: Alcohol and Substance Abuse
Pain Management

New Assay IDs Individuals With Major Depressive Disorder


HealthDay News
Updated: Feb 3rd 2012

 

new article illustration

FRIDAY, Feb. 3 (HealthDay News) -- A multi-assay, serum-based test can be used to distinguish individuals with major depressive disorder (MDD) from controls, with high specificity and sensitivity, according to a study published online Dec. 13 in Molecular Psychiatry.

George I. Papakostas, M.D., from the Massachusetts General Hospital and Harvard Medical School in Boston, and colleagues investigated the diagnostic performance of a multi-assay, serum-based test in patients with MDD. Serum levels of nine biomarkers in peripheral blood were compared in a pilot study involving 36 patients with MDD and 43 non-depressed controls. Results were replicated in a cohort of 34 patients with MDD. Biomarkers were selected on the basis of previous exploratory analyses. A positive test, indicating presence of MDD, was defined as a score of 50 or greater.

In the pilot study, the researchers found that the assay had a sensitivity of 91.7 percent and a specificity of 81.3 percent for differentiation of patients with MDD from controls. In the replication study, sensitivity and specificity were 91.1 and 81.0 percent, respectively.

"The results of the present study suggest that this test can differentiate MDD subjects from non-depressed controls with adequate sensitivity and specificity. Further research is needed to confirm the performance of the test across various age and ethnic groups, and in different clinical settings," the authors write.

Several authors disclosed financial ties to pharmaceutical and biotechnology companies, including Ridge Diagnostics, which funded the study and developed the diagnostic assay tested in the study.

Abstract
Full Text (subscription or payment may be required)




200 Cherry Street

Troy, AL 36081

Phone: (334) 566-6022

Fax: (334) 566-5346

 

 

[map]


powered by centersite dot net